# OnCo record tac01-cldn18-2 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/tac01-cldn18-2/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "tac01-cldn18-2" ;
  schema:name "TAC01-CLDN18.2"@en ;
  schema:description "TAC01-CLDN18.2 is an experimental TCR-T cell therapy from Triumvira Immunologics in phase 2 trials, aimed at Claudin 18.2."@en ;
  schema:url <https://onco.cc/drugs/tac01-cldn18-2/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=TAC01> ;
  onco:status "phase-2" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "TCR-T cell therapy" ;
  onco:technologies <https://onco.cc/technologies/tcr-t/> ;
  onco:targets <https://onco.cc/targets/cldn18-2/> ;
  onco:companies <https://onco.cc/companies/triumvira-immunologics/> ;
  onco:trials <https://onco.cc/trials/nct05862324/> .